Ozempic y otros medicamentos para adelgazar: ¿Cuál elegir?news2024-07-23T05:30:10+00:00July 23rd, 2024|The New York Times|
Ozempic and Weight Loss Drugs: Which Should You Choose?news2024-07-19T20:59:44+00:00July 19th, 2024|The New York Times|
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’snews2024-07-02T18:58:44+00:00July 2nd, 2024|The New York Times|
Algunos estados en EE. UU. afirman que no pueden costear Ozempic y otros medicamentos para perder pesonews2024-06-29T16:11:41+00:00June 29th, 2024|The New York Times|
Some States Say They Can’t Afford Ozempic and Other Weight Loss Drugsnews2024-06-25T21:09:10+00:00June 25th, 2024|The New York Times|
Médicos proponen tratar la obesidad antes que las enfermedades crónicasnews2024-06-22T09:03:56+00:00June 22nd, 2024|The New York Times|
Doctors Test the Limits of What Obesity Drugs Can Fixnews2024-06-18T09:13:35+00:00June 18th, 2024|The New York Times|
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lillynews2024-06-10T21:05:19+00:00June 10th, 2024|The New York Times|
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reportsnews2024-04-17T18:33:32+00:00April 17th, 2024|The New York Times|
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|